Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Politei

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Plos One|April 6, 2012
Mutations, clinical findings and survival estimates in South American patients with X-linked adrenoleukodystrophyFernanda dos Santos Pereira, Ursula Matte, Clarissa Troller Habekost, et al.
Journal of Medical Genetics|March 20, 2016
Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry RegistryAlberto Ortiz, Ademola Abiose, Daniel G Bichet, et al.
Molecular Genetics & Genomic Medicine|April 9, 2021
The benefits and challenges of family genetic testing in rare genetic diseases-lessons from Fabry diseaseDominique P Germain, Sergey Moiseev, Fernando Suárez-Obando, et al.
Pediatric Nephrology (Berlin, Germany)|July 11, 2018
Clinical parameters, LysoGb3, podocyturia, and kidney biopsy in children with Fabry disease: is a correlation possible?Juan Politei, Valeria Alberton, Oscar Amoreo, et al.
Medicina|October 25, 2013
[Guidelines for diagnosis, monitoring and treatment of Fabry disease], Pablo Neumann, Norberto Antongiovanni, et al.
Medicina|September 5, 2018
[Argentine consensus on late-onset Pompe's disease]Alberto Dubrovsky, Ernesto Fulgenzi, Eduardo L De Vito, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Plos One|April 6, 2012
Mutations, clinical findings and survival estimates in South American patients with X-linked adrenoleukodystrophyFernanda dos Santos Pereira, Ursula Matte, Clarissa Troller Habekost, et al.
Journal of Medical Genetics|March 20, 2016
Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry RegistryAlberto Ortiz, Ademola Abiose, Daniel G Bichet, et al.
Molecular Genetics & Genomic Medicine|April 9, 2021
The benefits and challenges of family genetic testing in rare genetic diseases-lessons from Fabry diseaseDominique P Germain, Sergey Moiseev, Fernando Suárez-Obando, et al.
Pediatric Nephrology (Berlin, Germany)|July 11, 2018
Clinical parameters, LysoGb3, podocyturia, and kidney biopsy in children with Fabry disease: is a correlation possible?Juan Politei, Valeria Alberton, Oscar Amoreo, et al.
Medicina|October 25, 2013
[Guidelines for diagnosis, monitoring and treatment of Fabry disease], Pablo Neumann, Norberto Antongiovanni, et al.
Medicina|September 5, 2018
[Argentine consensus on late-onset Pompe's disease]Alberto Dubrovsky, Ernesto Fulgenzi, Eduardo L De Vito, et al.
Pageof 4